Studies: Lenalidomid vs. Placebo in MDS patients without deletion 5qID TrialCC-5013-MDS-005EudraCT number2009-011513-24Clinicaltrials.gov identifierNCT01029262DescriptionA phase 3, multicenter, placebo-controlled study to compare the efficacy and safety of lenalidomide vs. placebo in subjects with transfusion dependent anemia dur to low or intermediate risk MDS and unresponsive to ESA therapies StatusactiveDisease
SponsorCelgeneJoseph-Wild-Str. 20 81829 München Germany Coordinating investigator
Principal investigator
Study nurse
|
|
